Acorda Therapeutics (NQ: ACOR )
0.5020 -0.0518 (-9.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Press Releases about Acorda Therapeutics
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
May 09, 2023
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which...
Topics Intellectual Property
Exposures Intellectual Property
ESTEVE Launches INBRIJA® in Spain
March 07, 2023
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
February 14, 2023
Acorda Therapeutics to Present at Sequire Biotechnology Conference
January 31, 2023
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
December 22, 2022
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
November 01, 2022
Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
October 21, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following